Memorial Sloan Kettering Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mskcc.org
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- First Posted Date
- 2016-11-28
- Last Posted Date
- 2025-05-25
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 82
- Registration Number
- NCT02974647
- Locations
- 🇺🇸
University of Miami, Miami, Florida, United States
🇺🇸Northwestern Medicine (Data collection and specimen analysis), Chicago, Illinois, United States
🇺🇸Dana Farber Cancer Institute, Boston, Massachusetts, United States
Ibrutinib for Patients With Follicular Lymphoma Without Complete Response to Initial Chemoimmunotherapy
- Conditions
- Follicular Lymphoma, Grade 2Follicular Lymphoma, Grade 1Follicular Lymphoma Grade IIIaFollicular Lymphoma
- Interventions
- First Posted Date
- 2016-11-17
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 2
- Registration Number
- NCT02966730
- Locations
- 🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
Durvalumab, an Anti-PDLI Antibody, and Tremelimumab, an Anti-CTLA4 Antibody, and Chemoradiation Before Surgery for Esophageal Cancer
- Conditions
- Esophageal AdenocarcinomaGastroesophageal Junction Adenocarcinoma
- Interventions
- Radiation: External beam radiation (EBRT)Procedure: esophagogastrectomy
- First Posted Date
- 2016-11-11
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 79
- Registration Number
- NCT02962063
- Locations
- 🇺🇸
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
🇺🇸Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Westchester, Harrison, New York, United States
Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer
- Conditions
- Esophageal CancerGastric Cancer
- Interventions
- First Posted Date
- 2016-11-03
- Last Posted Date
- 2023-03-16
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 37
- Registration Number
- NCT02954536
- Locations
- 🇺🇸
Memoral Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
Interest and Impact of Skin Cancer Genetic Testing
- Conditions
- Non-melanoma Skin Cancer (NMSC)
- Interventions
- Genetic: MC1R genotypingBehavioral: MC1R Testing WebsiteBehavioral: Baseline Survey
- First Posted Date
- 2016-10-21
- Last Posted Date
- 2023-01-20
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 53
- Registration Number
- NCT02941900
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
High Dose Carfilzomib for Newly Diagnosed Myeloma
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2016-10-18
- Last Posted Date
- 2024-10-14
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 37
- Registration Number
- NCT02937571
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment
- Conditions
- Central Nervous System TumorSolid TumorLeukemiaLymphoma
- Interventions
- First Posted Date
- 2016-10-13
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 14
- Registration Number
- NCT02932280
- Locations
- 🇺🇸
University of Texas, San Antonio, Texas, United States
🇺🇸Huntsman Cancer Institue, Salt Lake City, Utah, United States
🇺🇸Arkansas Children's Hospital, Little Rock, Arkansas, United States
Adaptation of Skills Training Manuals for Patients Receiving Hematopoietic Stem Cell Transplantation and Their Caregivers
- Conditions
- Post Hematopoietic Stem Cell Transplantation
- Interventions
- Behavioral: semi-structured interviews
- First Posted Date
- 2016-10-10
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 41
- Registration Number
- NCT02928185
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Factors Associated With the Use of a High Volume Cancer Center by Black Women With Ovarian Cancer: A Qualitative Study
- Conditions
- Primary Peritoneal CancerFallopian Tube CancerOvarian Cancer
- Interventions
- Behavioral: semi-structured interviews
- First Posted Date
- 2016-10-10
- Last Posted Date
- 2019-08-28
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 24
- Registration Number
- NCT02928549
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Local Injection of Pain Medication to Reduce Pain After Bone Marrow Procedures in Pediatric Neuroblastoma Patients
- Conditions
- Neuroblastoma
- Interventions
- Device: propofolBehavioral: Wong-Baker FACES® Pain Rating ScaleBehavioral: Post-procedural quality of life (QOL)
- First Posted Date
- 2016-10-05
- Last Posted Date
- 2022-11-08
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 56
- Registration Number
- NCT02924324
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States